Navigation Links
Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
Date:4/28/2010

BOCA RATON, Fla. April 28 /PRNewswire/ -- The X-GRAFT™ device is fashioned from solid human cortical bone, and is designed to acutely treat degenerative conditions of the spine. Utilizing the benefits of a minimal-exposure surgical procedure, the X-GRAFT™ is implanted into the interspinous space to provide stabilization of the spine, with minimal disturbance to the surrounding tissue. This is the first to market in a series of minimally invasive devices currently in development at Binder Biomedical and a key component of the MLIFF™ (Minimal - Lumbar, Interspinous, Facet Fusion) procedure.

Lawrence Binder, President of Binder Biomedical, Inc. commented: "The robust patent-pending design of the X-GRAFT™ device makes it an excellent option for stabilization of the lumbar spine following a decompression. The benefits of this system are evident from the favorable feedback we've received from our users. By offering a full range of sizes, as well as a comprehensive set of precision instruments, the X-GRAFT™ device has the unique ability to accommodate varying patient anatomy, while using minimal exposure, and fewer steps than traditional techniques."

The X-GRAFT™ device is procured and manufactured to exacting specifications by the University of Miami Tissue Bank (UMTB). This non-profit organization is the first civilian tissue bank in the U.S. and a university owned and operated tissue bank. UMTB is a comprehensive world-class facility, which conducts rigorous screening, recovery, autopsies, processing and packaging for all donors. Implantation of the 100th X-GRAFT™ is expected by the end of next month. Plans to expand national distributions are already underway, along with a full launch of the X-GRAFT™ device across the U.S. by the third quarter 2010. For more information on the X-GRAFT™ device please contact: sales@bindermed.com

Binder Biomedical, Inc. is a privately held medical device company located in Boca Raton, Florida. Founded on the basis of combining quality engineering with surgeon innovation, BBI provides surgeons with the highest quality medical devices for the treatment of complex orthopedic and neurological spinal disorders. Our development efforts are concentrated on products which incorporate advanced minimal exposure techniques, with the goal of providing better overall patient care. For more information about Binder Biomedical, Inc. please visit their website at:  www.bindermed.com


'/>"/>
SOURCE Binder Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
2. Competitive Technologies Selects RF
3. Binder as Public Relations Agency of Record
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017  ViewRay, Inc. (Nasdaq: ... first and only clinical MRI-guided radiation therapy system, announced ... of approximately $26.1 million through a private placement ... Management led the financing and was joined by ... LLC and Kearny Venture Partners, and an additional ...
(Date:1/19/2017)... , Jan. 18, 2017 The drug ... billion by 2021 from USD 1,179.20 billion in 2016, ... Increasing prevalence of chronic diseases, increasing demand for ... factors driving the growth of this market. Whereas, self-administration ... generic drugs offer significant growth opportunities for players operating ...
(Date:1/18/2017)... 18, 2017  Aprima Medical Software, a leading ... management (PM) and revenue cycle management (RCM) solutions ... a former reseller Healthcare Data Solutions (HDS) of ... Aprima will assume full support for HDS,s customers, ... practices across 15 states. Financial terms were not ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 2017 , ... “The Angel”: a heartwarming and earnest tale of faith ... his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former ... impassioned writer. , When asked of her new book, Marjorie says, “‘The Angel’ was ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches ... Kimberly Cordoves, a mother of three in Oklahoma City, and a devoted woman of faith. ... a book has been in the back of my mind for years, but actually doing ...
(Date:1/19/2017)... ... January 19, 2017 , ... Aerolib ... system for Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, ... education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning Management ...
(Date:1/19/2017)... ... 19, 2017 , ... LabRoots , the leading provider ... world, announces the launch of its newly redesigned website. The sleek new design ... and trending news, vital information on upcoming virtual events and webinars, all while ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery solutions to ...
Breaking Medicine News(10 mins):